ABT – Abbott Laboratories – Fundamental analysis, financial statements, key ratios, and fair value analysis

Abbott Laboratories

Healthcare
Medical Devices
68.11
1.89
2.85%
74.27
56.27
Stock Current Price
Change
Change %
52 Week High
52 Week Low

Financial Ratios

Earnings per Share (EPS)0.5
EPS Estimate Currrent Qtr0.81
Book Value Per Share17.48
Market Cap 120 Billion
PE Ratio 142.1
Dividend Yield1.8385521

Stock Yield

Stock Return 7 Days8.44%
Stock Return 15 Days1.92%
Stock Return 30 Days -4.28%
Stock Return 3 Months-3.69%
Stock Return One Year22.07%
Stock Return 3 Years24.20%

Stock Technical Analysis

Relative Strengh Index (14)34.62
Average True Range (14)2.39
Momentum (14)-6.31
Simple Moving Average (14) -6.31
Time Series Forecast (14)69.06
Time Series Forecast (30) 72.53

Stock News

Financial Statements

index2014201520162017
Revenue20 Billion20 Billion21 Billion27 Billion
Cost of Revenue9 Billion9 Billion9 Billion12 Billion
Gross Profit11 Billion12 Billion12 Billion15 Billion
Gross Margin (%)54.47%57.13%56.73%54.96%
Selling General and Administrative Expense7 Billion7 Billion7 Billion9 Billion
Other operating expenses1 Billion-290 Million3 Billion3 Billion
Earning Before Interest and Taxes EBIT3 Billion5 Billion2 Billion3 Billion
EBIT/Operating Margin (%)15.96%25.30%10.46%11.90%
Interest Expense150 Million163 Million431 Million904 Million
Other non-operating expenses/income0000
Earnings before Tax3 Billion5 Billion2 Billion2 Billion
Income Tax Expense797 Million577 Million350 Million2 Billion
Net Income2 Billion4 Billion1 Billion477 Million
Net Margin (%)11.28%21.68%6.71%1.74%
Earnings per share from operating income0.9494120.3997631.6572925.3048
Earnings per Diluted Share1.492.920.940.27
Dividends per Basic Common Share0.880.961.041.06
Payout ratio1.693183.041670.9038460.254717
Weighted average number of shares outstanding2 Billion2 Billion1 Billion2 Billion
index2017 Q42018 Q12018 Q22018 Q3
Revenue8 Billion7 Billion8 Billion8 Billion
Cost of Revenue3 Billion3 Billion3 Billion3 Billion
Gross Profit4 Billion4 Billion4 Billion4 Billion
Gross Margin (%)57.00%58.50%57.74%58.65%
Selling General and Administrative Expense2 Billion3 Billion2 Billion2 Billion
Other operating expenses1 Billion1 Billion1 Billion1 Billion
Earning Before Interest and Taxes EBIT856 Million667 Million1 Billion932 Million
EBIT/Operating Margin (%)11.28%9.03%12.90%12.17%
Interest Expense246 Million227 Million210 Million203 Million
Other non-operating expenses/income0000
Earnings before Tax610 Million440 Million792 Million729 Million
Income Tax Expense1 Billion22 Million59 Million166 Million
Net Income-828 Million418 Million733 Million563 Million
Net Margin (%)-0.00%5.66%9.44%7.35%
Earnings per share from operating income2.199616.93783.334115.17318
Earnings per Diluted Share-00.230.410.32
Dividends per Basic Common Share0.2650.280.280.28
Payout ratio-20.8214291.464291.14286
Weighted average number of shares outstanding2 Billion2 Billion2 Billion2 Billion
index2014201520162017
Cash and Equivalents4 Billion6 Billion19 Billion9 Billion
Trade and Non Trade Receivables4 Billion3 Billion3 Billion5 Billion
Inventory3 Billion3 Billion2 Billion4 Billion
Other current assets12 Billion14 Billion40 Billion21 Billion
Current Assets14 Billion14 Billion27 Billion20 Billion
Total Non-Current Assets28 Billion27 Billion26 Billion56 Billion
Total Assets41 Billion41 Billion53 Billion76 Billion
Trade and Non Trade Payables1 Billion1 Billion1 Billion2 Billion
Other current liabilities9 Billion8 Billion5 Billion7 Billion
Current Liabilities10 Billion9 Billion7 Billion9 Billion
Liabilities Non Current9 Billion11 Billion25 Billion36 Billion
Accumulated Retained Earnings Deficit23 Billion26 Billion26 Billion24 Billion
Shareholder’s equity other-1 Billion-4 Billion-5 Billion7 Billion
Shareholders Equity22 Billion21 Billion21 Billion31 Billion
Noncontrolling interests21 Billion18 Billion13 Billion18 Billion
Total Assets41 Billion41 Billion53 Billion76 Billion
index2017 Q42018 Q12018 Q22018 Q3
Cash and Equivalents9 Billion4 Billion3 Billion7 Billion
Trade and Non Trade Receivables5 Billion5 Billion5 Billion5 Billion
Inventory4 Billion4 Billion4 Billion4 Billion
Other current assets21 Billion10 Billion8 Billion17 Billion
Current Assets20 Billion15 Billion14 Billion18 Billion
Total Non-Current Assets56 Billion56 Billion54 Billion53 Billion
Total Assets76 Billion71 Billion68 Billion72 Billion
Trade and Non Trade Payables2 Billion2 Billion3 Billion3 Billion
Other current liabilities7 Billion7 Billion6 Billion10 Billion
Current Liabilities9 Billion9 Billion9 Billion13 Billion
Liabilities Non Current36 Billion30 Billion29 Billion28 Billion
Accumulated Retained Earnings Deficit24 Billion24 Billion24 Billion24 Billion
Shareholder’s equity other7 Billion8 Billion7 Billion7 Billion
Shareholders Equity31 Billion32 Billion31 Billion31 Billion
Noncontrolling interests18 Billion18 Billion18 Billion26 Billion
Total Assets76 Billion71 Billion68 Billion72 Billion
index2014201520162017
Net Cash Flow from Operations4 Billion3 Billion3 Billion6 Billion
Capital Expenditure-1 Billion-1 Billion-1 Billion-1 Billion
Net Cash Flow from Investing-202 Million406 Million-248 Million-10 Billion
Net Cash Flow from Financing-3 Billion-2 Billion11 Billion-5 Billion
Cash and Equivalents4 Billion6 Billion19 Billion9 Billion
index2017 Q42018 Q12018 Q22018 Q3
Net Cash Flow from Operations2 Billion1 Billion1 Billion2 Billion
Capital Expenditure-345 Million-275 Million-298 Million-354 Million
Net Cash Flow from Investing-3 Billion-238 Million-299 Million-323 Million
Net Cash Flow from Financing-112 Million-6 Billion-2 Billion2 Billion
Cash and Equivalents9 Billion4 Billion3 Billion7 Billion

Stock Price History

table